Quasar Medical Acquires Nordson to Enhance Contract Manufacturing in Medical Devices

Quasar Medical Expands Capabilities with Nordson Acquisition

Quasar Medical has achieved a pivotal advancement in the medical device sector by acquiring Nordson Corporation's design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This strategic move transforms Quasar into a fully integrated Contract Development and Manufacturing Organization (CDMO), enabling the company to provide comprehensive solutions that span from concept to commercialization for medical device original equipment manufacturers (OEMs) and innovators. The acquisition embodies a significant leap for Quasar, enhancing its operational capabilities and solidifying its position as a key player in the competitive MedTech landscape.

With this acquisition, Quasar expands its workforce by nearly 200 employees, including skilled development engineers and technicians. CEO Alex Wallstein underscores that this growth not only increases employment opportunities but also enhances Quasar's global footprint and fosters stronger partnerships with customers and suppliers throughout the product lifecycle. By integrating Nordson's facilities, Quasar aims to accelerate innovation and reduce time to market for new medical devices, which is crucial in a sector that demands rapid advancements and responsiveness to emerging healthcare needs. The strategic locations of the newly acquired facilities—both FDA-registered and ISO 13485-certified—further augment Quasar's customer accessibility and operational efficiency.

The Galway facility is poised to become an innovation hub, focusing on advanced product design, prototyping, and clinical innovation. Meanwhile, the Tecate site will bolster Quasar's capabilities in cost-effective, high-volume manufacturing, which is essential for facilitating smoother transitions from development to commercialization. COO Aviel Bohnik notes that this acquisition repositions Quasar as a strategic partner in the medical device development process, rather than merely a manufacturer. By offering a differentiated platform that combines innovation with operational excellence, Quasar is set to deliver high-value solutions across key global regions, emphasizing its commitment to advancing healthcare technology.

In addition to expanding its capabilities, Quasar's acquisition of Nordson's facilities enhances its competitive edge in the MedTech industry. The integration allows Quasar to offer a seamless, end-to-end solution for complex interventional devices, catering to the increasing demand for innovative medical solutions. The company's strategic emphasis on innovation and operational efficiency aligns well with the industry's trends toward minimally invasive procedures and advanced medical technologies.

This acquisition not only marks a significant milestone for Quasar Medical but also reshapes the landscape of contract manufacturing in the medical device sector, illustrating the importance of strategic growth and collaboration in driving industry advancements. As Quasar positions itself as a leader in the CDMO space, it is well-equipped to respond to the evolving needs of the medical device market.